Market revenue in 2023 | USD 44.9 million |
Market revenue in 2030 | USD 38.0 million |
Growth rate | -2.4% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 89.31% in 2023. Horizon Databook has segmented the UAE real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
The market in UAE is likely to witness lucrative market opportunities during the forecast period. Growth in the country can be attributed to government initiatives, such as launching awareness programs and providing funds for R&D.
As the UAE is a high-income country, the UAE government aims to provide universal access to updated and advanced healthcare services by 2021. Due to its vast financial resources and adequate government funding, the market in the UAE is advancing steadily.
In addition, laboratories conducting molecular diagnostics tests for infectious diseases are expected to increase the adoption of technologically advanced tests. For instance, the National Reference Laboratory conducts molecular diagnosis using RT-PCR for human papillomavirus, hepatitis, STIs, HIV, and other infectious diseases.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into UAE real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account